When Can We Trust Real‐World Data To Evaluate New Medical Treatments?

Concerns regarding both the limited generalizability and the slow pace of traditional randomized trials have led to calls for greater use of real‐world evidence (RWE) in the evaluation of new treatments or products. RWE studies often rely on real‐world data (RWD), including data extracted from healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Gregory E., Bindman, Andrew B., Dreyer, Nancy A., Platt, Richard, Watanabe, Jonathan H., Horberg, Michael, Hernandez, Adrian, Califf, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
White Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292968/
https://www.ncbi.nlm.nih.gov/pubmed/33932030
http://dx.doi.org/10.1002/cpt.2252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292968/
https://www.ncbi.nlm.nih.gov/pubmed/33932030
http://dx.doi.org/10.1002/cpt.2252

Ejemplares similares